Naftidrofuryl oxalate is a peripheral vascular agent and alpha-1-adrenergic antagonist used in the management of cerebral and peripheral vascular disorders, including the treatment of intermittent claudication.… Read more






Naftidrofuryl oxalate is a peripheral vascular agent and alpha-1-adrenergic antagonist used in the management of cerebral and peripheral vascular disorders, including the treatment of intermittent claudication. This category features the active pharmaceutical ingredient alongside a comprehensive range of related compounds, including pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled standards. These materials are essential for pharmaceutical laboratories during impurity profiling, analytical method validation, and routine quality control processes. By utilizing these characterized reference standards, analysts can accurately identify, isolate, and quantify degradation products or process-related impurities within drug formulations. The inclusion of stable isotope-labelled compounds provides internal standards necessary for rigorous analytical quantification, ensuring compliance with regulatory guidelines and the maintenance of high standards in the development and manufacturing of cardiovascular therapeutics.